For: | Bye W, Ishaq N, Bolin TD, Duncombe VM, Riordan SM. Overgrowth of the indigenous gut microbiome and irritable bowel syndrome. World J Gastroenterol 2014; 20(10): 2449-2455 [PMID: 24627582 DOI: 10.3748/wjg.v20.i10.2449] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i10/2449.htm |
Number | Citing Articles |
1 |
Barbara Jean Cordell, Anup Kanodia, Gregory K Miller. Case–Control Research Study of Auto-Brewery Syndrome. Global Advances in Health and Medicine 2019; 8 doi: 10.1177/2164956119837566
|
2 |
Huihui Guan, Yanni Pu, Chenglin Liu, Tao Lou, Shishang Tan, Mengmeng Kong, Zhonghan Sun, Zhendong Mei, Qibin Qi, Zhexue Quan, Guoping Zhao, Yan Zheng, Maria L. Marco. Comparison of Fecal Collection Methods on Variation in Gut Metagenomics and Untargeted Metabolomics. mSphere 2021; 6(5) doi: 10.1128/mSphere.00636-21
|
3 |
Hee Jo Yang, Jae Heon Kim. Role of microbiome and its metabolite, short chain fatty acid in prostate cancer. Investigative and Clinical Urology 2023; 64(1): 3 doi: 10.4111/icu.20220370
|
4 |
Yoshiharu Uno. Pilot Study on Gas Patterns of Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth Following Ingestion of Lactulose. Open Journal of Gastroenterology 2015; 5(11): 155 doi: 10.4236/ojgas.2015.511025
|
5 |
Alexey V. Melnik, Ricardo R. da Silva, Embriette R. Hyde, Alexander A. Aksenov, Fernando Vargas, Amina Bouslimani, Ivan Protsyuk, Alan K. Jarmusch, Anupriya Tripathi, Theodore Alexandrov, Rob Knight, Pieter C. Dorrestein. Coupling Targeted and Untargeted Mass Spectrometry for Metabolome-Microbiome-Wide Association Studies of Human Fecal Samples. Analytical Chemistry 2017; 89(14): 7549 doi: 10.1021/acs.analchem.7b01381
|
6 |
Wei-Lin Wang, Shao-Yan Xu, Zhi-Gang Ren, Liang Tao, Jian-Wen Jiang, Shu-Sen Zheng. Application of metagenomics in the human gut microbiome. World Journal of Gastroenterology 2015; 21(3): 803-814 doi: 10.3748/wjg.v21.i3.803
|
7 |
Jennifer M. Ayscue, Anjali S. Kumar. The ASCRS Textbook of Colon and Rectal Surgery. 2016; : 1107 doi: 10.1007/978-3-319-25970-3_62
|
8 |
|
9 |
D. M. Pinn, O. C. Aroniadis, L. J. Brandt. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?. Neurogastroenterology & Motility 2015; 27(1): 19 doi: 10.1111/nmo.12479
|
10 |
Robyn Nagel, Rebecca J. Traub, Richard J. N. Allcock, Marcella M. S. Kwan, Helle Bielefeldt-Ohmann. Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients. Microbiome 2016; 4(1) doi: 10.1186/s40168-016-0191-0
|
11 |
Shengyan Zhang, Gaichao Hong, Gangping Li, Wei Qian, Yu Jin, Xiaohua Hou. Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice. BMC Microbiology 2023; 23(1) doi: 10.1186/s12866-023-02772-6
|
12 |
Weilin Wang, Shaoyan Xu, Zhigang Ren, Jianwen Jiang, Shusen Zheng. Gut microbiota and allogeneic transplantation. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0640-8
|